Cronos-Black.png
Cronos Group Inc. Announces Third Quarter 2019 Results
12 nov. 2019 07h00 HE | Cronos Group Inc.
Closed Redwood U.S. Hemp-Based Products Platform and Cronos Fermentation Facility Acquisitions Announced the launch PEACE+™, A New Hemp-Derived U.S. Brand Advanced Operational Readiness of Cronos...
Cronos-Black.png
Cronos Group Establishes New Growth Opportunity in the United States with Acquisition of Hemp-Based Products Platform
02 août 2019 07h00 HE | Cronos Group Inc.
TORONTO, Aug. 02, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that it has entered into a definitive agreement to acquire...
MediPharm Labs and Ace Valley Launch Partnership
MediPharm Labs and Ace Valley Enter Vape Oil White Label Deal
19 juin 2019 06h00 HE | MediPharm Labs Corp.
TORONTO, June 19, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”), a leader in specialized, research-driven cannabis...
MediPharm logo.jpg
New York City Ichan School of Medicine at Mount Sinai and Renowned Global Researcher Dr. Hurd, Select MediPharm Labs to Support 500 Patient Major Clinical Study and “CBD International Consortium” to Develop Treatment of Opioid Addiction
22 mai 2019 09h08 HE | MediPharm Labs Corp.
TORONTO, May 22, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs”) a leader in specialized, research-driven cannabis extraction and cannabinoid...
MediPharm logo.jpg
MediPharm Labs Announces Q1 2019 Revenue of $22 Million and Adjusted EBITDA of $4.3 Million
10 mai 2019 07h01 HE | MediPharm Labs Corp.
TORONTO, May 10, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis...
Cronos-Black.png
Cronos Group Inc. Announces First Quarter 2019 Results
09 mai 2019 07h00 HE | Cronos Group Inc.
Cronos Group Closes C$2.4 Billion Strategic Investment from Altria Group Cronos Group Establishes Cronos Device Labs, a State-of-the-Art Vaporizer R&D Initiative NatuEra Receives License to...
Cronos-Black.png
Cronos Group Inc. Announces Fourth Quarter 2018 and Full Year 2018 Results
26 mars 2019 07h00 HE | Cronos Group Inc.
Closed C$2.4 Billion Strategic Growth Investment from Altria Group, Inc. Completed first harvest in Peace Naturals expansion to Building 4 Launched Two Recreational Brands: COVE™ and Spinach™ ...
Cronos-Black.png
Cronos Group Inc. Closes C$2.4 Billion Strategic Growth Investment from Altria Group, Inc.
08 mars 2019 08h30 HE | Cronos Group Inc.
Four New Directors Join Cronos Group Board Jerry Barbato Appointed Chief Financial Officer of Cronos Group; William Hilson Appointed Chief Commercial Officer TORONTO, March 08, 2019 (GLOBE...
Cronos-Black.png
Cronos Group Inc. Exits Investment in Whistler Medical Marijuana Corporation
04 mars 2019 07h00 HE | Cronos Group Inc.
TORONTO, March 04, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), confirmed today that it has sold all of its common shares in the capital...
Cronos-Black.png
Cronos Group Inc. to Hold Full Year and Fourth Quarter 2018 Earnings Conference Call
01 mars 2019 12h00 HE | Cronos Group Inc.
TORONTO, March 01, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), will announce its financial results and hold its Full Year and Fourth...